Literature DB >> 10753534

Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations.

D A Rew1, G D Wilson.   

Abstract

In the past two decades, the technology of laser cytometry and use of the halogenated thymidine (HP) analogues bromodeoxyuridine and iododeoxyuridine as proliferation labels, have allowed us to quantify the rate of cell turnover in tissues and tumours, in clinical samples as in laboratory models. The principal studies have used injection of bromo- or iododeoxyuridine to measure cell production rates in vivo. Flow cytometry (FCM) has been used to estimate the S phase labelling index (LI) and the S phase duration (Ts) and calculate the cell production rate, represented by the potential doubling time (Tpot). This has allowed calculation of time-dependent indices of proliferation from single biopsies of HP pulse labelled human tissues and tumours. In the first part of this two-part review, we describe the technique and its limitations as a biological assay. The second part summarizes the knowledge gained about cell production rates and the relevance that this information may have to future investigative, prognostic and treatment strategies. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753534     DOI: 10.1053/ejso.1999.0781

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Clinical correlates of circulating cell-free DNA tumor fraction.

Authors:  Joerg Bredno; Jafi Lipson; Oliver Venn; Alexander M Aravanis; Arash Jamshidi
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

2.  Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling.

Authors:  Sian M Tovey; Caroline J Witton; John M S Bartlett; Peter D Stanton; Jonathan R Reeves; Timothy G Cooke
Journal:  Breast Cancer Res       Date:  2004-03-23       Impact factor: 6.466

3.  Cell killing and resistance in pre-operative breast cancer chemotherapy.

Authors:  Paolo Ubezio; David Cameron
Journal:  BMC Cancer       Date:  2008-07-21       Impact factor: 4.430

4.  Activated lymphocytes as a metabolic model for carcinogenesis.

Authors:  Andrew N Macintyre; Jeffrey C Rathmell
Journal:  Cancer Metab       Date:  2013-01-23

5.  Modeling of non-small cell lung cancer volume changes during CT-based image guided radiotherapy: patterns observed and clinical implications.

Authors:  Hiram A Gay; Quendella Q Taylor; Fumika Kiriyama; Geoffrey T Dieck; Todd Jenkins; Paul Walker; Ron R Allison; Paolo Ubezio
Journal:  Comput Math Methods Med       Date:  2013-10-24       Impact factor: 2.238

6.  Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.

Authors:  Lik Hang Lee; Hua Yang; Gilbert Bigras
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

7.  In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model.

Authors:  Eleni Kolokotroni; Dimitra Dionysiou; Christian Veith; Yoo-Jin Kim; Jörg Sabczynski; Astrid Franz; Aleksandar Grgic; Jan Palm; Rainer M Bohle; Georgios Stamatakos
Journal:  PLoS Comput Biol       Date:  2016-09-22       Impact factor: 4.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.